|
1. Drugmaker recalls Xanax over quality issue Full story
2. FDA seeks additional safety data for Lilly GLP-1 pill Full story
3. AI governance, RCM, interoperability — Becker's hosts 4 days of strategy in Chicago. Apply to be a reviewer here.
4. What is ibogaine? 4 things to know Full story
5. 5 FDA moves shaping drug development, oversight Full story
6. Behavioral health referrals often fall short. See how to double first-visit attendance here.
7. Reddit data reveals new GLP-1 side effects: Study Full story
8. 6 new drugs in shortage Full story
Becker's Learning Opportunities
9. 10K workers surveyed: 1 in 5 considered quitting due to pain. What healthcare leaders can do now: here.
10. Learn how clinicians can identify inherited cardiovascular risk earlier here.
11. CMS is raising the bar on glycemic reporting. See what hospitals need to know here.
12. Becker's resources don't stop here — explore more
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
